Professor Dame Valerie Beral
Valerie Beral
DBE, AC, FRS
Emeritus Professor of Epidemiology
Valerie Beral studied medicine at Sydney University, Australia. After a few years of clinical work in Australia, New Guinea and the UK, she spent almost 20 years at the London School of Hygiene & Tropical Medicine working in the Department of Epidemiology. In 1988 she became the Director of the Cancer Epidemiology Unit in Oxford. A major focus of her work has been the role of reproductive, hormonal and infectious agents in cancer; she is Principal Investigator for the Million Women Study cohort of women’s health, and leads international collaborative studies of breast, ovarian and endometrial cancer. Current research is broadly aimed at understanding the major modifiable causes of morbidity and mortality associated with ageing in women, using the wealth of personal data collected from participants in the Million Women study cohort in combination with routinely-collected information on disease outcomes from linked NHS medical records. While Professor Beral continues to work on a wide range of cancers, these studies also include work on the causes of heart attack, stroke and blood clots, osteoporosis, fracture, and dementia.
Recent publications
-
Body mass index in midlife and risk of attempted suicide and suicide: prospective study of 1 million UK women.
Journal article
Geulayov G. et al, (2019), Psychol Med, 49, 2279 - 2286
-
Coffee and pancreatic cancer risk among never-smokers in the UK prospective Million Women Study.
Journal article
Zhou CD. et al, (2019), Int J Cancer, 145, 1484 - 1492
-
Body mass index and use and costs of primary care services among women aged 55-79 years in England: a cohort and linked data study.
Journal article
Kent S. et al, (2019), Int J Obes (Lond), 43, 1839 - 1848
-
Screen-detected and interval colorectal cancers in England: Associations with lifestyle and other factors in women in a large UK prospective cohort.
Journal article
Blanks R. et al, (2019), Int J Cancer, 145, 728 - 734
-
Diet and risk of glioma: combined analysis of 3 large prospective studies in the UK and USA.
Journal article
Kuan AS. et al, (2019), Neuro Oncol, 21, 944 - 952